1. Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor
    Yunpeng Yao et al, 2023, Cancer Immunology, Immunotherapy CrossRef
  2. The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
    Zhimei Zhou et al, 2021, Journal of Hepatocellular Carcinoma CrossRef
  3. Knowing the tumour microenvironment to optimise immunotherapy
    M. C. Merlano et al, 2019, Acta Otorhinolaryngologica Italica CrossRef
  4. Synthetic Agonists of Toll-like Receptors and Therapeutic Applications
    Sudhir Agrawal et al, 2019, Advances in Nucleic Acid Therapeutics CrossRef
  5. EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival
    Hanxiao Xu et al, 2019, Frontiers in Oncology CrossRef
  6. CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
    Zhongkun Zhang et al, 2021, Pharmaceutics CrossRef
  7. Dendritic Cells and Their Role in Immunotherapy
    Alycia Gardner et al, 2020, Frontiers in Immunology CrossRef

  8. RIG-I Promotes Cell Death in Hepatocellular Carcinoma by Inducing M1 Polarization of Perineal Macrophages Through the RIG-I/MAVS/NF-κB Pathway


    Bei Zhou et al, 2020, OncoTargets and Therapy CrossRef

  9. Toll-Like Receptor 9 Agonists in Cancer


    Lilit Karapetyan et al, 2020, OncoTargets and Therapy CrossRef
  10. Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
    Carmine Carbone et al, 2021, Journal for ImmunoTherapy of Cancer CrossRef
  11. Cytochrome P450 2U1 Is a Novel Independent Prognostic Biomarker in Breast Cancer Patients
    Bin Luo et al, 2020, Frontiers in Oncology CrossRef
  12. The Evolution of Antisense Oligonucleotide Chemistry—A Personal Journey
    Sudhir Agrawal, 2021, Biomedicines CrossRef
  13. Looking into a Better Future: Novel Therapies for Metastatic Melanoma
    Alessia Villani et al, 2021, Dermatology and Therapy CrossRef
  14. Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
    Samik Chakraborty et al, 2023, Frontiers in Immunology CrossRef
  15. Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
    Juan Bautista De Sanctis et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  16. Tailoring biomaterials and applications targeting tumor-associated macrophages in cancers
    Fangqi Jing et al, 2022, Frontiers in Immunology CrossRef
  17. Perspectives of Immunotherapy in Advanced Melanoma: Combinations and Sequencing
    A. M. Di Giacomo et al, 2021, New Therapies in Advanced Cutaneous Malignancies CrossRef
  18. Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors
    Aparna Raghavachar Chakravarti et al, 2023, Molecular Pharmaceutics CrossRef
  19. Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
    Asunción Espinosa-Sánchez et al, 2020, Frontiers in Oncology CrossRef
  20. Insight Into the Prospects for RNAi Therapy of Cancer
    Zhili Tian et al, 2021, Frontiers in Pharmacology CrossRef